The Twelve Days of Christmas: Not Exactly!


With Christmas rapidly approaching, Dr. D hopes all of the readers that celebrate Christmas have completed their shopping. FYI, Dr. D has not but will begin shopping with a vengeance ASAP. For this week’s guidance, the doctor will change things up a bit and share a song with the readers. Please remember to keep the song “The Twelve Days of Christmas” written by Frederic Austin (English composer) in 1909 in mind. The doctor is quite sure that my version will have Mr. Austin rolling over in his proverbial grave as Dr. D revises this objet trouvé (look-it-up) and gives it new meaning. Enjoy!
Twelve Days of Christmas
- On the first day of Christmas the FDA gave to me, a copy of a consent decree.
- On the second day of Christmas the FDA gave to me, two U.S. Marshalls, and a copy of a consent decree.
- On the third day of Christmas the FDA gave to me, three warning letters, two U.S. Marshalls, and a copy of a consent decree.
- On the fourth day of Christmas the FDA gave to me, four product seizures, three warning letters, two U.S. Marshalls, and a copy of a consent decree.
- On the fifth day of Christmas the FDA gave to me, FIVE Form 483s; four product seizures, three warning letters, two U. S. Marshalls and a copy of a consent decree.
- On the sixth day of Christmas the FDA gave to me, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U.S. Marshalls, and a copy of a consent decree.
- On the seventh day of Christmas the FDA gave to me, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U. S. Marshalls, and a copy of a consent decree.
- On the eight day of Christmas the FDA gave to me, eight enforcement reports, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U. S. Marshalls, and a copy of a consent decree.
- On the ninth day of Christmas the FDA gave to me, nine Class I recalls, eight enforcement reports, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U.S. Marshalls, and a copy of a consent decree.
- On the tenth day of Christmas the FDA gave to me, ten refusals to accept, nine Class I recalls, eight enforcement reports, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U.S. Marshalls, and a copy of a consent decree.
- On the eleventh day of Christmas the FDA gave to me, eleven MDRs, ten refusals to accept, nine Class I recalls, eight enforcement reports, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U. S. Marshalls and a copy of a consent decree.
- On the twelfth day of Christmas the FDA gave to me, twelve days to pay the establishment registration fee, eleven MDRs, ten refusals to accept, nine Class I recalls, eight enforcement reports, seven MedWatch alerts, six investigators inspecting, FIVE Form 483s; four product seizures, three warning letters, two U. S. Marshalls and a copy of a consent decree.
Takeaways
Dr. D’s only takeaway from this week’s guidance is the doctor hopes you had as much fun reading this week’s guidance as Dr. D had writing it! Please enjoy the holiday season with your families. For those readers celebrating Christmas, Merry Christmas from Dr. D! In closing, thank you again for joining Dr. D, and I hope you find value, or should the doctor say, enjoyment in the guidance provided. Until the next installment of DG, cheers from Dr. D. and best wishes for continued professional success.
Related Articles
-
The new guidance is intended to establish confidence in automation used for production or quality assurance systems and describe various methods and testing activities that may be applied to establish computer software assurance and meet regulatory software validation requirements.
-
The updated guidance document clarifies what constitutes a statement of the basis for the deficiency and includes examples of well-constructed deficiencies and industry responses to facilitate a more efficient review process.
-
The revised cybersecurity draft publication is not intended to be a checklist for healthcare organizations to follow, but rather a guide to help them comply with the HIPAA Security Rule.
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
About The Author
Dr. Christopher Joseph Devine
President
Dr. Christopher Joseph Devine is the President of Devine Guidance International, a consulting firm specializing in providing solutions for regulatory compliance, quality, supplier management, and supply-chain issues facing the device industry. Dr. Devine has 32 years of experience in quality assurance, regulatory compliance and program management. He is a senior member of the American Society for Quality (ASQ), a member of the Regulatory Affairs Professionals Society (RAPS), and a member of the Project Management Institute, and resides on several technical advisory boards. Dr. Devine received his doctorate from Northcentral University, with his doctoral dissertation titled, “Exploring the Effectiveness of Defensive-Receiving Inspection for Medical Device Manufacturers: A Mixed-Method Study.” Dr. Devine holds a graduate degree in organizational management (MAOM) and an undergraduate degree in business management (BSBM).